| LECTURES
|
| Friday,
December 5, 2003 |
| Time |
Title |
Speaker |
|
 |
| 8:15-8:20 |
Introduction/Welcome |
Ian Thompson, M.D
President, SUO
W. Marston Linehan,
M.D
Program Director
Eric Klein,
M.D.
Program Director
|
|
|
8:20-
9:40 |
Session I. GU Malignancies: Clues and Lessons Learned from Epidemiology |
Elizabeth Platz, Sc.D., M.D.
Moderator |
|
| |
|
Kidney Cancer |
Wong Chow, Ph.D.
(Presentation Not Available) |
|
| |
|
Testis Cancer |
Gary Schwartz,
Ph.D., M.P.H. |
|
| |
|
Prostate Cancer |
Otis Brawley, M.D. |
|
| |
|
Bladder Cancer |
Lee Moore, M.D. |
|
| |
|
Discussion: Drs. Platz, Chow, Schwartz, Brawley, and Moore |
|
|
| 9:40-10:00 |
|
Prostate Cancer Prevention Studies |
Peter Greenwald, M.D., Dr. P.H. |
  |
| |
|
Discussion |
|
|
|
| 10:00-10:40 |
Break
Poster Session I: Prostate and Bladder Cancer |
|
|
|
10:40-
11:45 |
Session II. Biomarkers for GU Cancer |
Edward Messing, M.D.
Moderator |
|
| |
|
Overview |
David Sidransky, M.D.
(Presentation Not Available)
|
|
| |
|
Proteomics |
Emanuel Petricoin, Ph.D. |
|
| |
|
Bladder Cancer Markers |
Edward Messing, M.D. |
|
| |
|
EDRN Overview |
Ian Thompson, M.D. |
|
| |
|
Discussion: Drs. Messing, Sidransky, Petricoin, and Thompson |
|
|
|
|
11:45-
1:15 |
Lunch
Poster
Session 2: Prostate Cancer |
|
|
|
|
| 1:15-2:00 |
Huggins Medal Presentation |
Ian Thompson, M.D.
Joseph A. Smith, M.D. |
|
| |
Huggins Lecture
Radical Prostatectomy: Past, Present and Future Perspectives |
Patrick C. Walsh, M.D. |
|
|
|
2:00-
2:30 |
Session III. Cancer Genomics |
|
|
| |
|
Does Prostate Cancer Have an Infectious Etiology? |
Elizabeth Platz, Sc.D., M.P.H. |
|
| |
|
Gene Expression Analysis in Prostate Cancer |
Arul Chinnaiyan, M.D., Ph.D. |
|
|
| 2:30-3:20 |
Session IV. Bladder Cancer
Role of Chemotherapy/ Radiotherapy in Management of Invasive Blader Cancer
(Case Presentations)
|
Mark Soloway, M.D.
Moderator |
|
| |
|
Panel:
Randall Millikan, M.D.
John Stein, M.D.
S. Machele Donat, M.D.
Paul Schellhammer, M.D.
Mary Gospodarowicz, M.D.
William Shipley, M.D. |
(Presentations Not Available) |
|
|
| 3:20-4:00 |
Break
Poster Session 3: Kidney/Bladder Cancer |
|
|
|
| 4:00-5:00 |
Session V. Management of Stage I Testis Cancer |
Paul Lange, M.D.
Moderator
|
|
| |
|
Open Lymphadenectomy is the Gold Standard |
Joel Sheinfeld, M.D. |
|
| |
|
Laparoscopic Lymphadenectomy |
Louis Kavoussi, M.D. |
|
| |
|
Primary Chemotherapy |
George Bosl, M.D. |
|
| |
|
Discussion: Drs. Lange, Sheinfeld, Kavoussi, and Bosl |
|
|
|
| |
|
|
|
|
| Saturday,
December 6, 2003 |
| Time |
Title |
Speaker |
|
|
8:00-
8:45 |
Session VII. Minimally Invasive Therapies: RCC and Upper Tract TCC |
Peter Pinto,
M.D.
Moderator |
|
| |
|
Cryotherapy |
Jihad Kaouk, M.D. |
|
| |
|
Radiofrequency Ablation |
McClellan M. Walther, M.D. |
|
| |
|
Laparoscopic Management of Upper Tract TCC |
Howard Winfield,
M.D. |
|
| |
|
Endoscopic Management of Upper Tract TCC |
Thomas Jarrett,
M.D. |
|
| |
|
Discussion:
Drs. Pinto, Kaouk, Walther, Winfield, and Jarrett |
|
|
|
8:45-
10:00 |
Session VIII. Molecular Therapeutics: Targets for Screening, Therapy, and Prevention |
Dan Theodorescu, M.D., Ph.D.
Moderator |
|
| |
|
The Biology of MSR1 |
Jianfeng Xu,
M.D. |
|
| |
|
The Biology of RNaseL/HPC1 |
Eric Klein,
M.D.
(Presentation Not Available) |
|
| |
|
Postate Cancer Molecular Targets |
Robert Reiter,
M.D.
(Presentation Not Available) |
|
| |
|
Prostate Cancer Therapeutic Targets |
Georg Bartsch, M.D. |
|
| |
|
Kidney Cancer Genes: Molecular Targets for Therapy |
W. Marston Linehan, M.D. |
|
| |
|
Kidney Cancer: Molecular Therapeutics Clinical Trials |
Walter Stadler, M.D. |
|
| |
|
Discussion:
Theodorescu, Xu, Klein, Reiter, Bartsch, Linehan, and Stadler |
|
|
|
|
10:00-
10:15 |
Poster
Session Awards |
Michael C. Gong,
M.D.,
John Phillips, M.D.
Christian Pavlovich, M.D.
|
|
|
10:15-
11:15 |
Session IX. The Rising PSA After Definitive Therapy: What It Means and What Can/Should We Do |
Paul Lange,
M.D.
Moderator |
|
| |
|
Surrogate End Point for Prostate Cancer Specific Mortality Following Surgery or Radiation Therapy |
Anthony D'Amico, M.D., Ph.D. |
|
| |
|
PSA Velocity in Hormone Refractory Prostate Cancer |
Kenneth Pienta,
M.D. |
|
| |
|
Discussion:
Drs. Lange, D'Amico, and Pienta |
|
|
|
11:15-
Noon |
Session X. Late Breaking Developments |
(Session Not Recorded) |
|
|
| Noon-1:00 |
Session XI. Highlights of GU SPORES |
Jorge Gomez, M.D., Ph.D.
Moderator |
|
| |
|
Phillip Febbo, M.D.
|
|
|
| |
|
William Ellis, M.D. |
|
|
| |
|
John C. Morris, M.D. |
|
|
| |
|
Kenneth Pienta, M.D. |
|
|
| |
|
Paul Mathew, M.D. |
|
|
|
| 1:00 |
Concluding
Remarks and Adjourn |
Ian Thompson, M.D. |
|
|
